Theralase Technologies Inc. (TLTFF)
USD 0.15
(4.23%)
USD 0.15
(4.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 342.96 Thousand CAD | 133.14% |
| 2022 | -1.03 Million CAD | 71.69% |
| 2021 | -3.65 Million CAD | 53.06% |
| 2020 | -7.78 Million CAD | 37.21% |
| 2019 | -12.4 Million CAD | -1099.96% |
| 2018 | -1.03 Million CAD | -307.13% |
| 2017 | -253.9 Thousand CAD | 91.45% |
| 2016 | -2.97 Million CAD | 31.58% |
| 2015 | -4.34 Million CAD | -125.8% |
| 2014 | -1.92 Million CAD | -8.76% |
| 2013 | -1.76 Million CAD | -8505.41% |
| 2012 | -20.54 Thousand CAD | 44.93% |
| 2011 | -37.29 Thousand CAD | 72.83% |
| 2010 | -137.27 Thousand CAD | 87.88% |
| 2009 | -1.13 Million CAD | -4473.44% |
| 2008 | -24.76 Thousand CAD | 95.13% |
| 2007 | -507.96 Thousand CAD | -208.61% |
| 2006 | -164.59 Thousand CAD | -1338.51% |
| 2005 | 13.29 Thousand CAD | -66.53% |
| 2004 | 39.7 Thousand CAD | -36.35% |
| 2003 | 62.38 Thousand CAD | 164.27% |
| 2002 | -97.06 Thousand CAD | 33.33% |
| 2001 | -145.59 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -87.17 Thousand CAD | -134.9% |
| 2024 Q1 | 249.82 Thousand CAD | -27.16% |
| 2023 Q4 | 342.96 Thousand CAD | 96.97% |
| 2023 FY | 342.96 Thousand CAD | 133.14% |
| 2023 Q2 | 23.78 Thousand CAD | -72.55% |
| 2023 Q3 | 174.12 Thousand CAD | 632.12% |
| 2023 Q1 | 86.62 Thousand CAD | 108.37% |
| 2022 FY | -1.03 Million CAD | 71.69% |
| 2022 Q4 | -1.03 Million CAD | 47.21% |
| 2022 Q3 | -1.96 Million CAD | -102.46% |
| 2022 Q1 | -2.56 Million CAD | 29.9% |
| 2022 Q2 | -968.31 Thousand CAD | 62.22% |
| 2021 Q4 | -3.65 Million CAD | 25.8% |
| 2021 FY | -3.65 Million CAD | 53.06% |
| 2021 Q1 | -6.6 Million CAD | 15.13% |
| 2021 Q2 | -5.83 Million CAD | 11.73% |
| 2021 Q3 | -4.92 Million CAD | 15.55% |
| 2020 Q1 | -10.78 Million CAD | 13.06% |
| 2020 Q2 | -9.49 Million CAD | 11.98% |
| 2020 FY | -7.78 Million CAD | 37.21% |
| 2020 Q4 | -7.78 Million CAD | 10.33% |
| 2020 Q3 | -8.68 Million CAD | 8.5% |
| 2019 Q2 | -966.05 Thousand CAD | 42.16% |
| 2019 Q3 | -14.81 Million CAD | -1433.93% |
| 2019 Q1 | -1.67 Million CAD | -61.56% |
| 2019 Q4 | -12.4 Million CAD | 16.29% |
| 2019 FY | -12.4 Million CAD | -1099.96% |
| 2018 Q2 | -83.47 Thousand CAD | -186.95% |
| 2018 FY | -1.03 Million CAD | -307.13% |
| 2018 Q4 | -1.03 Million CAD | -106.86% |
| 2018 Q1 | -29.09 Thousand CAD | 88.54% |
| 2018 Q3 | -499.7 Thousand CAD | -498.63% |
| 2017 Q2 | -932.02 Thousand CAD | 41.69% |
| 2017 FY | -253.9 Thousand CAD | 91.45% |
| 2017 Q4 | -253.9 Thousand CAD | 69.97% |
| 2017 Q3 | -845.37 Thousand CAD | 9.3% |
| 2017 Q1 | -1.59 Million CAD | 46.19% |
| 2016 Q3 | -796.71 Thousand CAD | 61.65% |
| 2016 Q2 | -2.07 Million CAD | 42.44% |
| 2016 Q1 | -3.6 Million CAD | 16.86% |
| 2016 Q4 | -2.97 Million CAD | -272.81% |
| 2016 FY | -2.97 Million CAD | 31.58% |
| 2015 FY | -4.34 Million CAD | -125.8% |
| 2015 Q4 | -4.34 Million CAD | 21.49% |
| 2015 Q3 | -5.52 Million CAD | 21.13% |
| 2015 Q1 | -8.53 Million CAD | -344.02% |
| 2015 Q2 | -7.01 Million CAD | 17.88% |
| 2014 FY | -1.92 Million CAD | -8.76% |
| 2014 Q4 | -1.92 Million CAD | 10.21% |
| 2014 Q3 | -2.14 Million CAD | 23.74% |
| 2014 Q2 | -2.8 Million CAD | -193.24% |
| 2014 Q1 | -957.45 Thousand CAD | 45.83% |
| 2013 FY | -1.76 Million CAD | -8505.41% |
| 2013 Q4 | -1.76 Million CAD | -281557.17% |
| 2013 Q2 | -34.36 Thousand CAD | -154.15% |
| 2013 Q1 | -13.52 Thousand CAD | 34.16% |
| 2013 Q3 | 628.00 CAD | 101.83% |
| 2012 Q2 | -67.19 Thousand CAD | -794.78% |
| 2012 Q1 | -7510.00 CAD | 79.86% |
| 2012 FY | -20.54 Thousand CAD | 44.93% |
| 2012 Q3 | -1590.00 CAD | 97.63% |
| 2012 Q4 | -20.54 Thousand CAD | -1191.82% |
| 2011 FY | -37.29 Thousand CAD | 72.83% |
| 2011 Q1 | -446.85 Thousand CAD | -225.51% |
| 2011 Q2 | -64.81 Thousand CAD | 85.49% |
| 2011 Q4 | -37.29 Thousand CAD | -591.38% |
| 2011 Q3 | 7590.00 CAD | 111.71% |
| 2010 Q2 | -766.54 Thousand CAD | 28.24% |
| 2010 FY | -137.27 Thousand CAD | 87.88% |
| 2010 Q4 | -137.27 Thousand CAD | 68.01% |
| 2010 Q1 | -1.06 Million CAD | 5.68% |
| 2010 Q3 | -429.12 Thousand CAD | 44.02% |
| 2009 FY | -1.13 Million CAD | -4473.44% |
| 2009 Q1 | 85.88 Thousand CAD | 446.83% |
| 2009 Q2 | 85.3 Thousand CAD | -0.68% |
| 2009 Q3 | 86.73 Thousand CAD | 1.68% |
| 2009 Q4 | -1.13 Million CAD | -1405.77% |
| 2008 Q1 | -468.9 Thousand CAD | 7.69% |
| 2008 FY | -24.76 Thousand CAD | 95.13% |
| 2008 Q4 | -24.76 Thousand CAD | -17.01% |
| 2008 Q3 | -21.16 Thousand CAD | 87.87% |
| 2008 Q2 | -174.46 Thousand CAD | 62.79% |
| 2007 Q1 | -46.6 Thousand CAD | 71.68% |
| 2007 Q2 | 42.67 Thousand CAD | 191.55% |
| 2007 Q4 | -507.96 Thousand CAD | 23.8% |
| 2007 Q3 | -666.6 Thousand CAD | -1662.2% |
| 2007 FY | -507.96 Thousand CAD | -208.61% |
| 2006 Q4 | -164.59 Thousand CAD | -9468.13% |
| 2006 Q1 | 16.73 Thousand CAD | 25.91% |
| 2006 Q2 | -43.02 Thousand CAD | -357.11% |
| 2006 FY | -164.59 Thousand CAD | -1338.51% |
| 2006 Q3 | 1757.00 CAD | 104.08% |
| 2005 FY | 13.29 Thousand CAD | -66.53% |
| 2005 Q1 | 54.05 Thousand CAD | 36.13% |
| 2005 Q2 | -1525.00 CAD | -102.82% |
| 2005 Q3 | -14.42 Thousand CAD | -846.03% |
| 2005 Q4 | 13.29 Thousand CAD | 192.12% |
| 2004 Q4 | 39.7 Thousand CAD | 110.84% |
| 2004 Q3 | -366.45 Thousand CAD | 12.47% |
| 2004 Q1 | -275.56 Thousand CAD | -541.72% |
| 2004 FY | 39.7 Thousand CAD | -36.35% |
| 2004 Q2 | -418.67 Thousand CAD | -51.93% |
| 2003 Q3 | -66.13 Thousand CAD | 16.81% |
| 2003 Q4 | 62.38 Thousand CAD | 194.34% |
| 2003 Q2 | -79.49 Thousand CAD | 12.28% |
| 2003 Q1 | -90.62 Thousand CAD | 6.64% |
| 2003 FY | 62.38 Thousand CAD | 164.27% |
| 2002 Q4 | -97.06 Thousand CAD | 3.1% |
| 2002 FY | -97.06 Thousand CAD | 33.33% |
| 2002 Q1 | -134.73 Thousand CAD | 0.0% |
| 2002 Q2 | -131.73 Thousand CAD | 2.23% |
| 2002 Q3 | -100.17 Thousand CAD | 23.96% |
| 2001 FY | -145.59 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | 156.596% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 97.687% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -58.336% |
| Polarean Imaging plc | -5.94 Million USD | 105.768% |
| Avitar, Inc. | 5.17 Million USD | 93.368% |
| AVITA Medical, Inc. | -26.23 Million USD | 101.307% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 4999.557% |
| Össur hf. | 395.08 Million USD | 99.913% |
| Zecotek Photonics Inc. | 2.76 Million USD | 87.585% |
| QHSLab, Inc. | 1.72 Million USD | 80.175% |
| Wellstar International, Inc. | 51.36 Million USD | 99.332% |
| Össur hf. | 395.08 Million USD | 99.913% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 107.428% |
| Escalon Medical Corp. | 315.68 Thousand USD | -8.642% |
| Aurora Spine Corporation | 1.9 Million USD | 82.021% |
| BrainsWay Ltd. | -10.32 Million USD | 103.323% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 85.799% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 98.108% |
| Vivos Inc. | -1.59 Million USD | 121.539% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.949% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 29.623% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 163.397% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 46.428% |
| Nanomix Corporation | 11.38 Million USD | 96.989% |
| Theraclion SA | -5.86 Million EUR | 105.848% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 91.395% |
| Positron Corporation | 1.68 Million USD | 79.668% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 78.709% |
| Lombard Medical, Inc. | 11.49 Million USD | 97.016% |
| ALR Technologies Inc. | 19.14 Million USD | 98.209% |
| Stratec SE | 119.12 Million USD | 99.712% |
| Vycor Medical, Inc. | 1.05 Million USD | 67.428% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -523.637% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -268.016% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 102.488% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 98.862% |
| VMS Rehab Systems, Inc. | 133.52 USD | -256767.136% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 76.621% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 45.64% |
| Odyssey Group International, Inc. | 2.1 Million USD | 83.729% |
| United American Healthcare Corporation | -9.32 Million USD | 103.677% |
| ECGI Holdings, Inc. | 3.17 Million USD | 89.185% |
| Capital Group Holdings, Inc. | -3508.00 USD | 9876.767% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -30.596% |
| Urologix, Inc. | 4.61 Million USD | 92.568% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 91.852% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 89.704% |
| SS Innovations International, Inc. | 1.18 Million USD | 71.066% |
| Qualis Innovations, Inc. | 6671.00 USD | -5041.193% |
| Smith & Nephew plc | 2.77 Billion USD | 99.988% |
| NIOX Group Plc | -23.93 Million USD | 101.433% |
| Fuse Medical, Inc. | 1.75 Million USD | 80.463% |
| Broncus Holding Corporation | -81.42 Million USD | 100.421% |
| Brain Scientific Inc. | 2.11 Million USD | 83.79% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 98.488% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -767.025% |